Meeting
2016 ASCO Annual Meeting
Oncological outcomes of function preserving gastrectomy for early gastric cancer: A multicenter case-controlled analysis comparing pylorus-preserving gastrectomy versus conventional distal gastrectomy.
Authors
Masaki Aizawa
Niigata Cancer Center Hospital, Niigata, Japan
Masaki Aizawa , Michitaka Honda , Naoki Hiki , Takahiro Kinoshita , Hiroshi Yabusaki , Souya Nunobe , Hidehito Shibasaki , Atsushi Matsuki , Takayuki Abe , Masahiro Watanabe , Atsushi Nashimoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4034)
DOI
10.1200/JCO.2016.34.15_suppl.4034
Abstract #
4034
Poster Bd #
26
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Long-term outcomes after laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study (JCOG1401).
First Author: Shinichi Sakuramoto
Poster
2015 ASCO Annual Meeting
A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer (JCOG0912): Analysis of the safety and short-term clinical outcomes.
First Author: Masakazu Takagi
Poster
2023 ASCO Annual Meeting
Five-year overall survival with S-1 plus docetaxel as adjuvant treatment in curatively resected pStage III gastric cancer in JACCRO GC-07.
First Author: Wataru Ichikawa
Poster
2021 ASCO Annual Meeting
Biomarker-oriented study of durvalumab in combination with olaparib and paclitaxel in gastric cancer: A phase 2 trial-in-progress.
First Author: Tae Yong Kim